IDSA: Cabotegravir + rilpivirine long-acting antiretroviral therapy beneficial in HIV
Cabotegravir + rilpivirine (CAB+RPV) long-acting (LA) antiretroviral therapy (ART) consistently maintains virologic suppression among virologically suppressed adults with HIV, according to a study presented ...
27 Oct 20:40 · Medical Xpress